268 related articles for article (PubMed ID: 33893026)
1. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.
Ali F; Russell C; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
Int J Drug Policy; 2021 Jul; 93():103237. PubMed ID: 33893026
[TBL] [Abstract][Full Text] [Related]
2. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
[TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
[TBL] [Abstract][Full Text] [Related]
4. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada.
Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S
Harm Reduct J; 2022 Apr; 19(1):38. PubMed ID: 35436936
[TBL] [Abstract][Full Text] [Related]
5. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
6. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
[TBL] [Abstract][Full Text] [Related]
7. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
[TBL] [Abstract][Full Text] [Related]
8. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
[TBL] [Abstract][Full Text] [Related]
9. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
[TBL] [Abstract][Full Text] [Related]
10. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
11. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.
Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D
Harm Reduct J; 2024 May; 21(1):94. PubMed ID: 38750575
[TBL] [Abstract][Full Text] [Related]
12. Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study.
Ali F; Kaura A; Russell C; Bonn M; Bruneau J; Dasgupta N; Imtiaz S; Martel-Laferrière V; Rehm J; Shahin R; Elton-Marshall T
Harm Reduct J; 2023 Jul; 20(1):99. PubMed ID: 37516836
[TBL] [Abstract][Full Text] [Related]
13. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
14. 'More of the same, but worse than before': A qualitative study of the challenges encountered by people who use drugs in Nova Scotia, Canada during COVID-19.
Comeau E; Bonn M; Wildeman S; Herder M
PLoS One; 2023; 18(4):e0283979. PubMed ID: 37018353
[TBL] [Abstract][Full Text] [Related]
15. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada.
Park H; Linthwaite B; Dussault C; Halavrezos A; Chalifoux S; Sherman J; Del Balso L; Buxton JA; Cox J; Kronfli N
Int J Prison Health; 2022 Dec; 19(3):464-73. PubMed ID: 36519779
[TBL] [Abstract][Full Text] [Related]
17. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
18. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
[TBL] [Abstract][Full Text] [Related]
19. A Qualitative Exploration of the Functional, Social, and Emotional Impacts of the COVID-19 Pandemic on People Who Use Drugs.
Kelly EL; Reed MK; Schoenauer KM; Smith K; Scalia-Jackson K; Kay Hill S; Li E; Weinstein L
Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955107
[TBL] [Abstract][Full Text] [Related]
20. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
